Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Metadata
Title
Cistitis hemorrágica
Authors
María Sereno Moyano
Beatriz Castelo Fernández
Noelia Martínez Jáñez
Enrique Casado Sáenz
Manuel González Barón
Publication date
01-08-2003
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2003
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02709986

Other articles of this Issue 6/2003

Clinical and Translational Oncology 6/2003 Go to the issue

Originales

CHOP con intensificación de dosis en linfomas no Hodgkin agresivos

Notas Clínicas

Massive intra-peritoneal non-functioning malignant paraganglioma

Sección Docente

Extended lymphadenectomies in the treatment of digestive tract carcinomas (I). Esophagus and stomach

Notas Clínicas

Multiple neuroblastoma or multiple diseases?

Originales

The Borrmann classification. Interobserver and intraobserver agreement of endoscopists in an oncological hospital

Originales

Intraoperative ultrasound for ethanol tumor ablation and liver resection for malignant tumors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits